Andreas Correa
Papers
2
Total Citations
17
H-Index
2
About
Dr. Andreas Correa is a leading urologic oncologist whose research centers on the surgical management of upper tract urothelial carcinoma (UTUC), with a particular focus on robotic-assisted techniques and kidney-sparing approaches. As a key member of the ROBUUST 2.0 collaborative group, Dr. Correa has made significant contributions to understanding the role of robot-assisted distal ureterectomy (RADU) in high-risk distal ureteral tumors. His landmark 2024 study, cited 10 times, demonstrated that RADU can achieve excellent oncological outcomes while preserving renal function, challenging the traditional paradigm of radical nephroureterectomy for these patients. Dr. Correa has also advanced the evidence base for neoadjuvant chemotherapy in locally advanced and node-positive UTUC, with a 2024 study of 7 citations providing crucial real-world data from the ROBUUST 2.0 Registry. His work is particularly impactful for its focus on high-risk patient populations where treatment decisions are most complex. By combining rigorous multicenter data with innovative surgical techniques, Dr. Correa is helping to establish new standards of care that prioritize both cancer control and quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2